Citation:De Jonge PJ, van Blankenstein M, Looman CW, Casparie MK, Meijer GA, Kuipers EJ 2010

From Cancer Guidelines Wiki

Citation


de Jonge PJ, van Blankenstein M, Looman CW, Casparie MK, Meijer GA, Kuipers EJ. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study. Gut 2010 Aug;59(8):1030-6 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/20639249.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?Professor David Whiteman B Med Sci, MBBS (Hons) PhD FAFPHMcompleted
Are there groups of patients with non-dysplastic BO that require more frequent surveillance?Dr Henry Tocompleted
Are there groups of patients with BO that can be discharged from surveillance?Conjoint Associate Professor Philip Craigcompleted

Compare quality appraisals for each clinical question

Cited by

  1. Are there groups of patients with BO that can be discharged from surveillance?
  2. Are there groups of patients with non-dysplastic BO that require more frequent surveillance?
  3. What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?